JPharmBiomedAnal投稿指南.docx
- 文档编号:8752983
- 上传时间:2023-02-01
- 格式:DOCX
- 页数:27
- 大小:25.56KB
JPharmBiomedAnal投稿指南.docx
《JPharmBiomedAnal投稿指南.docx》由会员分享,可在线阅读,更多相关《JPharmBiomedAnal投稿指南.docx(27页珍藏版)》请在冰豆网上搜索。
JPharmBiomedAnal投稿指南
ASponsoredJournaloftheAmericanAssociationofPharmaceuticalScientists
GuideforAuthors
ContributionswhichfulfiltheAimsandScopeofthejournalwillbewelcomedfromanywhereintheworld.ThelanguageofthejournalisEnglish.Allmanuscriptsshouldbewritteninthepasttenseandimpersonalstyle.
Submissionofanarticleimpliesthattheworkdescribedhasnotbeenpublishedpreviously(exceptintheformofanabstractoraspartofapublishedlectureoracademicthesis),thatitisnotunderconsiderationforpublicationelsewhere,thatitspublicationisapprovedbyallauthorsandtacitlyorexplicitlybytheresponsibleauthoritieswheretheworkwascarriedout,andthat,ifaccepted,itwillnotbepublishedelsewhereinthesameform,inEnglishorinanyotherlanguage,withoutthewrittenconsentofthePublisher.
Uponacceptanceofanarticle,Authorswillbeaskedtotransfercopyright.Formoreinformationoncopyrightsee
.Thistransferwillensurethewidestpossibledisseminationofinformation.AletterwillbesenttothecorrespondingAuthorconfirmingreceiptofthemanuscript.Aformfacilitatingtransferofcopyrightwillbeprovided.
Ifexcerptsfromothercopyrightedworksareincluded,theAuthor(s)mustobtainwrittenpermissionfromthecopyrightownersandcreditthesource(s)inthearticle.ElsevierhaspreprintedformsforusebyAuthorsinthesecases:
contactElsevier'sRightsDepartment,Oxford,UK:
phone(+44)1865843830,fax(+44)1865853333,e-mailpermissions@.RequestsmayalsobecompletedonlineviatheElsevierhomepage,
Thisjournalisaninternationalmediumforthepublicationoforiginalresearchreportsandauthoritativereviewsonpharmaceuticalandbiomedicalanalysis.Itcoverstheinterdisciplinaryaspectsofanalysisinthepharmaceuticalandbiomedicalsciences,includingrelevantdevelopmentsinanalyticalmethodology,instrumentation,computationandinterpretation.Submissionsonnovelapplicationsfocussingondrugpurityandstabilitystudies,pharmacokinetics,therapeuticmonitoring,metabolicprofiling;drug-relatedaspectsofanalyticalbiochemistryandforensictoxicology;qualityassuranceinthepharmaceuticalindustryarewelcome.
SinceclassicalUV-VISmethods(includingderivativespectrophotometricandmulti-wavelengthmeasurements),solventextraction,basicelectroanalyticalmethods,titrimetry,etc.arewellestablished,studiesinsuchareasareacceptedforpublicationinexceptionalcasesonly,ifauniqueandsubstantialadvantageoverpresentlyknownsystemsisdemonstrated.Studiesreportedshouldbesupportedbyademonstrationoftheapplicationofthemethodtorealsamples.Nopapersdealingwiththedeterminationofdrugsinbiologicalsamplesbasedmerelyonspikedsamplesareacceptable.Indeterminingthesuitabilityofsubmittedarticlesforpublication,particularscrutinywillbeplacedonthedegreeofnoveltyandsignificanceoftheresearchandtheextenttowhichitaddstoexistingknowledgeinpharmaceuticalandbiomedicalanalysis.Inallsubmissionstothejournal,authorsmustaddressthequestionofhowtheirproposedmethodologycompareswithpreviouslyreportedmethods.Asubstantialbodyofworkcannotbefractionatedintodifferentshorterpapers.
Thejournalisdirectedtowardstheneedsofacademic,clinical,governmentandindustrialanalysisandpresentsauniqueforumforthediscussionofcurrentdevelopmentsattheinterfacebetweenpharmaceutical,biochemicalandclinicalanalysis.
Submission:
AuthorsshouldsubmittheirmanuscriptonlinetooneofthejournaleditorsbyusingtheOnlineSubmissiontoolfortheJournalofPharmaceuticalandBiomedicalAnalysis.TosubmitonlineauthorsshoulduploadtheirarticleasaLaTeX,Microsoft®(MS)Word®,WordPerfect®,orPostScriptviathejournal'sAuthorGatewayhomepageatThesystemgeneratesanAdobeAcrobatPDFversionofthearticlewhichisusedforthereviewingprocess.Authors,ReviewersandEditorssendandreceiveallcorrespondencebye-mailandnopapercorrespondenceisnecessary.
Manuscriptsmustbedouble-spacedononesideonly,withatleast2.5cm(1inch)marginsallround.Allpagesshouldbenumberedandthefirstpagemustcontainthefollowing:
title;namesofallauthorswiththeiraddressesinfull.Fullinstructionshowtousetheonlinesubmissiontoolareavailableattheonlinesubmissionwebsiteofthejournal
PeerReview:
AllmanuscriptswillbeassessedbytwoindependentReviewers.ReviewswillbeassessedbyoneindependentReviewer.AuthorswillbeinformedoftheReviewers'commentsand,wherepermissionisgiven,oftheiridentities.
Proofs:
ProofsmustbereturnedtothePublisherwithinthetimeperiodspecified,afterwhichtheEditorsreservetherighttomakeanynecessarycorrectionstoapaperpriortopublication.OnlynecessaryamendmentswillbeacceptedatthisstageandanychangesnotofatypographicalnaturemaybechargedtotheAuthor.
Reprints:
Twenty-fivereprintsofeachpaperwillbesenttothecorrespondingauthorfreeofcharge.Additionalcopiesmaybeorderedontheformaccompanyingtheproofs.
GeneralConsiderations:
Pleasewriteyourtextingoodenglish(AmericanorBritishusageisaccepted,butnotamixtureofthese).
LanguagePolishing:
Uponrequest,ElsevierwilldirectauthorstoanagentwhocancheckandimprovetheEnglishoftheirpaper(beforesubmission).Pleasecontactauthorsupport@forfurtherinformation.
Anumberofthecommonlyacceptedabbreviationsthatmaybeusedwithoutfurtherdefinitionaredescribedinthejournal'slistofabbreviations.Anyothertermstobeabbreviatedshouldfirstbedefinedandthenfollowedimmediatelybytheabbreviationinparentheses.Articlesshouldbewritteninthepasttenseandintheimpersonalstyle(I,we,me,us,etc.aretobeavoided,exceptintheAcknowledgementssection).
Thefollowingtypesofpaperswillbeconsideredforpublication:
Reviews:
Authorswishingtosubmitareviewshouldsendashortsynopsistooneoftheeditorsbeforestartingdetailedworkonamanuscript.Thestructureandpresentationofareviewarticlewillnormallybeattheauthor'sdiscretion.Reviewsmayberelativelyshort,i.e.dealingwithalimitedsubject,orlongerandmoregeneralinnature.
FullLengthResearchPapers:
ThesepapersshoulddescribeindetailoriginalandimportantpiecesofworkinthefieldscoveredbytheJournal.Eachpapershouldbesetoutasfollows:
Title:
Thisshouldbeasbriefaspossibleconsistentwithclarity.Authors'namesshouldbegivenwithfulladdresses.Thenameofthecorrespondingauthor,towhomreprintswillbeaddressed,shouldbemarkedwithanasteriskandthecorrespondingauthor'stelephonenumber;faxnumberandemailaddressshouldbeindicated.
Keywords:
Thedetailedsubjectindexofthejournaliscompiledannuallywiththeaidofkeywordsfurnishedbyauthors.Thesekeywords(orkeyphrases)mustbecarefullyselectedtoreflectthescopeofthepaper.Generalwords(e.g.immunoassay,chromatography)shouldbeavoidedinfavourofmorespecificterms(e.g.enzymeimmunoassay,reversed-phasechromatography).Normallysixkeywordsorkeyphraseswillbesufficient.
Abstract:
Thisshouldbeaconciseself-containedsummaryoftheprincipalresultsoftheworkdescribed,togetherwithanyessentialexperimentaldetails.
Introduction:
Thisshouldbeaconcisestatementofthebackgroundtotheworkpresented,includingrelevantearlierwork,suitablyreferenced.Theimportanceofthesubjectandreasonsforthereaders'presumedinterestshouldbeindicated.
Experimental(orMaterialsandMethods):
Thissectionshouldcontainreasonablydetailedaccountsofmaterialsandexperimentalprocedures,and/orreferencestopreviouslypublishedmethodsused.Sufficientinformationshouldbeprovidedtopermitrepetitionoftheworkbyotherworkers.Whendescribingmixedsolventsforchromatography,extractionorotherpurposes,thefollowingconventionmustbeadopted:
solventA–solventB–solventC(a:
b:
c,v/v/v)or(a:
b:
c,w/w/w)wherea:
b:
caretheproportions(byvolumeorweightasappropriate)ofthecomponentsA,BandC,respectively.
Themethodofpreparationofbuffersshouldbeclearlyexpressed,withthepHvalueandmolaritystatedinparentheses,e.g.sodiumacetate(pH4.7;0.1M).Formixedsolventsystems,itshouldbeclearlystatedwhetherthepHvaluequotedisthepHoftheoriginalaqueouscomponentortheapparentpH(i.e.pH*)ofthemixedsolventsystem.Typicalexamplesofmobilephasesemployedinliquidchromatographymightbe:
acetonitrile–sodiumoctylsulphate(10mM)–sodiumacetate(pH4.7;0.1M)(25:
25:
50,v/v/v),andacetonitrile–sodiumoctylsulphate(10mM)–sodiumacetate(0.1M)(25:
25:
50,v/v/v)(pH*4.7).Discussionoftheoptimisationprocedurefortheproposedmethod/assayshouldbegivenindetail.
Results:
Theimportantresultsoftheworkshouldbeclearlystatedandillustratedwherenecessarybytablesandfigures.Thelattershouldbekepttotheminimumconsistentwithclarity.Inparticularfiguresshowinglinearanalyticalresponsecurvesaregenerallyunnecessary,andwillbedeleted.Thedetailsofslope,intercept,standarderrorofslope,standarderrorofintercept,concentrationrangeandnumberofstandardsareessentialandtheyshouldbegiveninthetextortabulated.Thissectionmayalsocontainexperimentaldetailsuchasthatobtainedwhendescribingthedevelopmentofnewanalyticalprocedures.Itshouldincludeallrelevantvalidat
- 配套讲稿:
如PPT文件的首页显示word图标,表示该PPT已包含配套word讲稿。双击word图标可打开word文档。
- 特殊限制:
部分文档作品中含有的国旗、国徽等图片,仅作为作品整体效果示例展示,禁止商用。设计者仅对作品中独创性部分享有著作权。
- 关 键 词:
- JPharmBiomedAnal 投稿 指南